Coverage
-
June 29, 2017
Allergan Inc. plans to pay $13 million to the federal government and 19 states to end a False Claims Act suit in Pennsylvania that accused the company of shelling out kickbacks to eye doctors to boost sales of its drugs, the whistleblowers' attorneys said Thursday.
6 other articles on this case.
View all »